Akums Drugs and Pharmaceutical (AKUMS) — Defensive Interval Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Defensive Interval Ratio of 697 days as of March 2026. Defensive assets of Rs20.92 Billion (cash Rs-, short-term investments Rs12.95 Billion, receivables Rs7.97 Billion) cover 697 days of daily cash needs of Rs29.99 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Akums Drugs and Pharmaceutical Defensive Interval Ratio (2022–2026)
This chart shows how Akums Drugs and Pharmaceutical's Defensive Interval Ratio has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the ratio stands at 697 days, meaning defensive assets of Rs20.92 Billion can fund 697 days of operations without new revenue. For the complete balance sheet picture, see AKUMS current and non-current assets.
Annual Defensive Interval Ratio for Akums Drugs and Pharmaceutical (2022–2026)
The table below presents the year-by-year Defensive Interval Ratio for Akums Drugs and Pharmaceutical from 2022 to 2026, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Akums Drugs and Pharmaceutical short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (INR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2026 | 697 days | Rs20.92 Billion | Rs29.99 Million/day | Rs- | Rs12.95 Billion | ▲ +183 days |
| 2025 | 514 days | Rs12.59 Billion | Rs24.49 Million/day | Rs- | Rs4.81 Billion | ▲ +209 days |
| 2024 | 305 days | Rs10.11 Billion | Rs33.17 Million/day | Rs- | Rs1.77 Billion | ▲ +30 days |
| 2023 | 274 days | Rs9.51 Billion | Rs34.67 Million/day | Rs- | Rs988.92 Million | ▲ +7 days |
| 2022 | 267 days | Rs9.32 Billion | Rs34.86 Million/day | Rs- | Rs481.56 Million | — |